The Food and Drug Administration galvanizes its work to make more drugs available OTC in the US with recommendations on compliance with labeling requirements for the content and format of statements of identity and strength.
The agency also torques its support for improving consumers’ self-care choices with recommendations on clearly stating the amounts contained in...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?